Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.
Cortesi, Paolo Angelo; D'Angiolella, Lucia Sara; Vellucci, Renato; Allegri, Massimo; Casale, Giuseppe; Favaretti, Carlo; Kheiraoui, Flavia; Cesana, Giancarlo; Mantovani, Lorenzo Giovanni.
Afiliação
  • Cortesi PA; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
  • D'Angiolella LS; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
  • Vellucci R; Palliative Care and Pain Therapy Unit, University Hospital of Careggi, Florence, Italy.
  • Allegri M; Department of Surgical Sciences, Anesthesia Intensive Care and Pain Therapy Service, Azienda Ospedaliera, University of Parma, Parma, Italy.
  • Casale G; ANTEA Center, Antea Formad Educational, Rome, Italy.
  • Favaretti C; Institute of Public Health, Catholic University of the Sacred Heart, Rome, Italy.
  • Kheiraoui F; Institute of Public Health, Catholic University of the Sacred Heart, Rome, Italy.
  • Cesana G; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
  • Mantovani LG; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
PLoS One ; 12(6): e0179523, 2017.
Article em En | MEDLINE | ID: mdl-28654672
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Fentanila / Dor Irruptiva / Dor do Câncer / Analgésicos Opioides Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Fentanila / Dor Irruptiva / Dor do Câncer / Analgésicos Opioides Idioma: En Ano de publicação: 2017 Tipo de documento: Article